<SEC-DOCUMENT>0001553350-17-000109.txt : 20170125
<SEC-HEADER>0001553350-17-000109.hdr.sgml : 20170125
<ACCEPTANCE-DATETIME>20170125160124
ACCESSION NUMBER:		0001553350-17-000109
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170123
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170125
DATE AS OF CHANGE:		20170125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		17546414

	BUSINESS ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
		BUSINESS PHONE:		9549794788

	MAIL ADDRESS:	
		STREET 1:		1441 SW 29 AVENUE
		CITY:			POMPANO BEACH
		STATE:			FL
		ZIP:			33069
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Current Report</TITLE>
<META NAME="author" CONTENT="EDGAR FILING LLC">
<META NAME="date" CONTENT="04/28/2014">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<A NAME="eolPage1"></A><P style="margin:0px">&nbsp;<A NAME="FIS_TOP_OF_DOCUMENT"></A>&nbsp;<A NAME="B416715_8K_HTM"></A>&nbsp;<A NAME="FIS_FORM"></A>&nbsp;<A NAME="FIS_UNIDENTIFIED_TABLE"></A></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial; font-size:13.5pt" align=center><B>FORM 8-K</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center><B>CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial" align=center>Date of report (Date of earliest event reported): January 23, 2017</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=153.6 /><TD width=153.6 /><TD width=153.6 /><TD width=153.6 /><TD width=153.6 /></TR>
<TR><TD style="margin-top:0px" valign=top width=768 colspan=5><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>PetMed Express, Inc.<BR>
</U></B> (Exact name of registrant as specified in its charter)</P>
<P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>Florida</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>000-28827</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center><B><U>65-0680967</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(State or other jurisdiction<BR>
of incorporation)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(Commission<BR>
File Number)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding:0px; font-size:12pt">&nbsp;</P></TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=153.6><P style="margin:0px; padding-right:1.067px; font-family:Arial" align=center>(I.R.S. Employer<BR>
Identification No.)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=768 /></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>1441 S.W. 29</U></B><B><U><SUP>th</SUP></U></B><B><U> Avenue, &nbsp;Pompano Beach, FL &nbsp;33069</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Address of principal executive offices) (Zip Code)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=751.4 /><TD width=16.6 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>(954) 979-5995</U></B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=751.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Registrant&#146;s telephone number, including area code)</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=16.6><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=768 /></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center><B><U>Not Applicable</U></B></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=768><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman" align=center>(Former name or former address, if changed since last report)</P>
</TD></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=24.267 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings; font-size:12pt">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings; font-size:12pt">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings; font-size:12pt">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=24.267><P style="margin:0px; font-family:Wingdings; font-size:12pt">&#168;</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD><A NAME="eolPage2"></A><A NAME="FIS_OTHER_EVENTS"></A></TR>
</TABLE>
<P style="line-height:11.25pt; margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="line-height:11.25pt; margin:0px; page-break-before:always"><BR>
<BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=24.267 /><TD /></TR>
</TABLE>
<P style="line-height:0.05pt; margin:0px"><BR></P>
<P style="margin-top:12.533px; margin-bottom:0px"><BR></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman"><B>Item 8.01&nbsp;&nbsp;&nbsp;Other Events.</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:24px; font-family:Arial,Times New Roman" align=justify>On January 23, 2017, PetMed Express, Inc. discussed its financial results for the quarter ended December 31, 2016. &nbsp;A copy of this conference call transcript is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman"><B>Item 9.01&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=77.733 /><TD width=24.2 /><TD width=666.067 /></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">(d)</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Exhibits.</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=77.733><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=24.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=666.067><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">99.1 &#150; Conference call transcript by PetMed Express, Inc. on January 23, 2017.</P>
</TD><A NAME="FIS_EXHIBIT_INDEX"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center><B>EXHIBIT INDEX</B></P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0><TR height=0 style="font-size:0"><TD width=80.8 /><TD width=17.133 /><TD width=652.933 /><TD width=17.133 /></TR>
<TR><TD style="margin-top:0px" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>Exhibit No.</U></P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>Description</U></P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=80.8><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman; color:#0000FF"><A HREF="pets_ex99z1.htm"><U>99.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=652.933><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Conference call transcript by PetMed Express, Inc. on January 23, 2017.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=17.133><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><A NAME="FIS_SIGNATURES"></A></TR>
</TABLE>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center><B>SIGNATURES</B></P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin-top:15px; margin-bottom:0px; font-family:Arial,Times New Roman">Dated: January 25, 2017</P>
<P style="line-height:11.25pt; margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD /><TD width=46.4 /><TD width=338.2 /></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=384.6 colspan=2><P style="margin:0px; padding-right:2.4px; font-family:Arial,Times New Roman">PETMED EXPRESS, INC.</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">By:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman"><U>/s/ Bruce S. Rosenbloom</U></P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Name:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Bruce S. Rosenbloom</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Title:</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">Chief Financial Officer</P>
</TD></TR>
<TR><TD style="margin-top:0px" valign=top><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=46.4><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD><TD style="margin-top:0px" valign=top width=338.2><P style="margin:0px; padding-right:1.067px; font-family:Arial,Times New Roman">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR></P>
<P style="margin-top:12.533px; margin-bottom:0px; font-family:Arial,Times New Roman" align=center>2</P>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR></P>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR></P>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR></P>
<P style="margin-top:12.533px; margin-bottom:0px" align=center><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: F4FB43C8 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pets_ex99z1.htm
<DESCRIPTION>CONFERENCE CALL TRANSCRIPT
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>CONFERENCE CALL TRANSCRIPT</TITLE>
<META NAME="date" CONTENT="01/25/2017">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>PETMED EXPRESS, INC.</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>QUARTER ENDED DECEMBER 31, 2016</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>CONFERENCE CALL TRANSCRIPT</B></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center><B>JANUARY 23, 2017 AT 8:30 A.M. ET<A NAME="_GoBack"></A></B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Welcome to the PetMed Express, Incorporated, doing business as 1-800-PetMeds conference call to review the financial results for the third fiscal quarter that ended on December 31, 2016. At the request of the company, this conference call is being recorded. Founded in 1996, 1-800-PetMeds is America&#146;s Largest Pet Pharmacy delivering prescription and non-prescription pet medications and other health products for dogs and cats direct to the consumer. 1-800-PetMeds markets its products through national television, online, direct mail and print advertising campaigns which direct consumers to order by phone or on the Internet and aim to increase recognition of the PetMeds family of brand names. 1-800-PetMeds provides an attractive alternative for obtaining pet medication in terms of convenience, price, ease of ordering and rapid home delivery. At this time, I would now like to turn the call over to the Company&#146;s Chief Financial Officer, Mr. Bruce Rosenbloom. Sir, you may begin.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Bruce Rosenbloom:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. I would like to welcome everybody here today. Before I turn the call over to Mendo Akdag, our President and Chief Executive Officer, I would like to remind everyone that the first portion of this conference call will be listen only until the question-and-answer session which will be later in the call. Also certain information that will be included in this press conference may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or the Securities and Exchange Commission that may involve a number of risks and uncertainties. These statements are based on our beliefs as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties and assumptions. Actual future results may vary significantly based on a number of factors that may cause the actual results or events to be materially different from future results, performance or achievements expressed or implied by the statement. We have identified various risk factors associated with our operations in our most recent annual report and other filings with the Securities and Exchange Commission. Now let me introduce today&#146;s speaker, Mendo Akdag, President and Chief Executive Officer of 1-800-PetMeds. Mendo.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you, Bruce. Welcome and thank you for joining us. Today we will review the highlights of our financial results. We&#146;ll compare our third fiscal quarter and nine months ended on December 31, 2016, to last year&#146;s quarter and nine months, ended on December 31, 2015. Before we get to the financials, I&#146;m pleased to report that in December 2016, we completed the move to our new corporate headquarters and distribution center in Delray Beach. </P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the third fiscal quarter ended on December 31, 2016, our sales were $52.9 million compared to sales of $50.9 million for the same period the prior year, an increase of 3.8%. For the nine months ended on December 31, 2016, sales were $186.1 million compared to sales of $179.3 million for the nine months the prior year, again, an increase of 3.8%. The increases in sales were due to increases in new order and reorder sales. The average order value for the quarter was approximately $81 compared to $78 for the same quarter of the prior year.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the third fiscal quarter, net income was $4.8 million, or $.24 diluted per share compared to $4.9 million, or $.24 diluted per share for the same quarter the prior year, a decrease to net income of 1.4%. For the nine months, net income was $16.3 million, or $.80 diluted per share compared to $15.1 million or $.75 diluted per share a year ago, an increase to net income of 7.7%. The net income for the quarter was impacted by one-time expenses of approximately $125,000 related to the move and a $96,000 income tax true up for the prior fiscal year.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>New order sales increased by 4.4% to $7.9 million for the quarter compared to $7.6 million for the same period the prior year. For the nine months, the new order sales increased by 7.4% to $31.9 million compared to $29.7 million for the same period last year. Reorder sales increased by 3.7% to $44.9 million for the quarter compared to reorder sales of $43.3 million for the same quarter the prior year. For the nine months, reorder sales increased by 3.1% to $154.2 million compared to $149.6 million for the same period a year ago.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 1 of 4</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; font-size:12pt; page-break-before:always">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>We acquired approximately 99,000 new customers in our third fiscal quarter compared to 98,000 for the same period the prior year. And we acquired approximately 388,000 new customers in the nine-months compared to 374,000 for the same period a year ago. &nbsp;For the quarter, approximately 83% of our sales were generated on our web site compared to 81% for the same quarter last year, which resulted in a 5.6% increase in online sales.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>The seasonality in our business is due to the proportion of flea, tick and heartworm medications in our product mix. Spring and summer are considered peak seasons with fall and winter being the off seasons.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the third fiscal quarter, our gross profit as a percent of sales was 31.5% compared to 32.9% for the same period a year ago. For the nine months, our gross profit as a percent of sales was 30.7% compared to 32.7% for the nine months a year ago. The percentage decreases were due to increases in product costs on certain brands and additional discounts given to customers to increase sales. Our general and administrative expenses as a percent of sales was 10.1% for the quarter compared to 9.8% for the same quarter the prior year, and for the nine months, it was 9.2% compared to 9.0% for the same period a year ago. One-time expenses related to the move were approximately $125,000, about 2 basis points for the quarter.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>For the quarter, we spent $3.2 million in advertising compared to $4.0 million for the same quarter the prior year. For the nine months, we spent $13.3 million for advertising, compared to $18.1 million for the nine months a year ago. Advertising costs of acquiring a customer for the quarter was $32 compared to $41 for the same quarter the prior year, and for the nine months, it was $34 compared to $49 for the nine months the prior year.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; padding-left:144px; font-family:Arial,Times New Roman" align=justify>We had $47.9 million in cash and cash equivalents and $14.9 million in inventory with no debt as of December 31, 2016. Net cash from operations for the nine months was $31.6 million compared to $22.6 million for the nine months last year. The increase was mainly due to decreases in inventory. &nbsp;For the nine months, we spent $9.9 million in property and equipment updating our infrastructure in our new facility. This ends the financial review. Operator, we&#146;re ready to take questions. Operator?</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. I&#146;m sorry, go ahead.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We&#146;re ready to take questions.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. I&#146;ll now begin the question and answer session. If you would like to ask a question, please press star followed by the number 1, unmute your phone and record your first and your last name and your company clearly when prompted. &nbsp;This information is required to introduce your question. Now, to cancel your question, please press star followed by the number 2. Please stand by for our first question. Our first question comes from Erin Wilson, Credit Suisse. Your line is now open.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Great. Thanks for taking my question. Can you explain some of the dynamics influencing the gross margin trend? You mentioned some additional discounts and promotional activity. I guess, how should we think about that trend going forward? Will it improve? Are you seeing any sort of changes there? If you can explain the dynamics, that would be great. Thanks.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Going forward, we would anticipate that gross margins should stabilize or the drop should not be as dramatic as you have seen in the last few quarters with a caveat that will also depend on how the competition behaves price-wise.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>And on the competitive landscape, I mean, what are - how would you characterize it currently especially with some of the specialty retail customers taking a more omni-channel approach? And also you have kind of a consolidated manufacturer base. If you could comment on kind of those two dynamics, that would be great. Thanks.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Over-the-counter products are very competitive and the market is crowded. &nbsp;But there is also a shift to new generation medications.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 2 of 4</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; font-size:12pt; page-break-before:always">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and are you seeing an uptick or an early uptick in any sort of flea, tick or heartworm sales at this point?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>I would say it&#146;s probably similar to last year so far.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Erin Wilson:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. All right, thank you so much.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You&#146;re welcome.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Our next question comes from Anthony Lebiedzinski, Sidoti &amp; Company. Your line is now open.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Yes, good morning. Thank you for taking the question. So, you know, clearly looking at the new customer acquisition cost, another decline, so my question is, is this really as good as it gets in terms of new customer acquisition costs or are there any other levers that you can pull? Obviously, you eliminated TV advertising about a year ago - so what are your thoughts going forward on that please?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>We will do some testing but we&#146;ll see what the numbers come at, so we&#146;ll follow the data. So at this point, it appears it will be similar to what you have seen the last few quarters, again, with a caveat that obviously if any new competition enters the market, it could be impacted.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Got it. Okay, and as far as the AOV gains, the average order value, what do you attribute that to? Are you seeing more gains on the RX side versus OTC? Or is it consistent in both segments?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>I can tell you that there is a shift to higher-priced items which are really new generation medications.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, and lastly, I guess, you know, as far as - actually just a couple of line items from your income statement, obviously with the new facility, your depreciation expenses have gone up, plus your other income. Is this sort of the way we should think about a new quarterly run rate? Or any sort of help with that would be certainly helpful. Thank you.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Depreciation will probably be about half a million dollars a quarter, about $2 million a year, but it will be offset by elimination of the lease expense for our old facility and also by the lease income.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, is this - so the lease income, all of that goes into the other income line?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Yes.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay, so that&#146;s roughly $130,000 per quarter. Is that a fair number to expect or&#133;?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>No, there is advertising income in the number, too.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Anthony Lebiedzinski:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Okay. All right, I&#146;ll touch base later with Bruce maybe. All right, thanks. </P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You&#146;re welcome. </P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Next question comes from Jeffrey Hoffman, Marathon Partners. Your line is now open.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Jeffrey Hoffman:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Great. Thank you for taking my question. Can you just explain what might be happening with inventory as it&#146;s declined over the past few quarters?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Well, we&#146;re being more efficient. Our inventory will fluctuate based on the promotional buying opportunities, so we were able to reduce it in the last two quarters.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Jeffrey Hoffman:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>And do you believe that is more of a sustainable buying opportunity going forward?</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>It depends on if there are any promotional buying opportunities that requires us to buy in advance. Obviously we will take advantage of that and that will increase the inventory so it&#146;s difficult to tell.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 3 of 4</P>
<P style="margin:0px" align=center><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; font-size:12pt; page-break-before:always">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Jeffrey Hoffman:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Perfect. Thank you so much.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You&#146;re welcome.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. Our next question comes from George Baxter, Sabrepoint Capital. Your line is now open.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">George Baxter:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>My question has been answered. Thank you.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>You&#146;re welcome.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. And as a reminder, to ask a question, please press star followed by the number 1 and record your first and your last name and your company name when prompted. At this time, we show no questions in queue.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Mendo Akdag:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you. We are currently focusing on improving our operational efficiency in our new facility. This wraps up today&#146;s conference call. Thank you for joining us. Operator, this ends the conference call. Thank you.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:144px; font-family:Arial,Times New Roman; float:left">Coordinator:</P>
<P style="margin:0px; padding-left:144px; text-indent:-2px; font-family:Arial,Times New Roman" align=justify>Thank you for participating. You may disconnect now.</P>
<P style="margin:0px; clear:left" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px; font-family:Arial,Times New Roman" align=center>Exhibit 99.1 Page 4 of 4</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: 840F2349 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
